Top Suppliers:I want be here

63659-18-7

63659-18-7 structure
63659-18-7 structure
  • Name: Betaxolol
  • Chemical Name: betaxolol
  • CAS Number: 63659-18-7
  • Molecular Formula: C18H29NO3
  • Molecular Weight: 307.43
  • Catalog: API Circulatory system medication Antiarrhythmic drug
  • Create Date: 2018-06-11 18:49:24
  • Modify Date: 2024-01-03 17:02:28
  • Betaxolol is a selective beta1 adrenergic receptor blocker used in the treatment of hypertension and glaucoma.Target: Beta1 Adrenergic ReceptorBetaxolol is a cardioselective beta-adrenergic receptor blocking agent. Betaxolol (5 mg/kg via i.p. injection) was administered at 24 and then 44 h following the final chronic cocaine administration. Animals treated with betaxolol during cocaine withdrawal exhibited a significant attenuation of anxiety-like behavior characterized by increased time spent in the open arms and increased entries into the open arms compared to animals treated with only saline during cocaine withdrawal. Betaxolol did not produce anxiolytic-like effects in control animals treated chronically with saline [1]. Betaxolol produces less systemic beta 2- and possibly beta 1-adrenergic receptor blockade than either timolol or levobunolol. Betaxolol may be relatively safer to use in patients with reactive airway disease than either timolol or levobunolol [2].

Name betaxolol
Synonyms (±)-1-(p-(2-(Cyclopropylmethoxy)ethyl)phenoxy)-3-(isopropylamino)-2-propanol Hydrochloride
1-{4-[2-(cyclopropylmethoxy)ethyl]phenoxy}-3-[(1-methylethyl)amino]propan-2-ol hydrochloride
Betaxolol
MFCD00242958
(+/-)-1-{p-[2-(cyclopropylmethoxy) ethyl] phenoxy}-3-isopropylamino-2-propanol
1-{4-[2-(Cyclopropylmethoxy)ethyl]phenoxy}-3-[(1-methylethyl)amino]propan-2-olhydrochlorid
Betaxololum
2-Propanol, 1-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]-3-[(1-methylethyl)amino]-, hydrochloride (1:1)
1-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]-3-[(1-methylethyl)amino]-2-propanol
1-{4-[2-(Cyclopropylmethoxy)ethyl]phenoxy}-3-(isopropylamino)-2-propanol hydrochloride (1:1)
Betaxolol [INN:BAN]
1-{4-[2-(cyclopropylmethoxy)ethyl]phenoxy}-3-(propan-2-ylamino)propan-2-ol hydrochloride (1:1)
Betaxolol hydrochloride
Kerlone
1-{4-[2-(cyclopropylméthoxy)éthyl]phénoxy}-3-[(1-méthyléthyl)amino]propan-2-ol chlorhydrate
Betaxolol (TN)
1-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]-3-(propan-2-ylamino)propan-2-ol
1-{4-[2-(Cyclopropylmethoxy)-ethyl]-phenoxy}-3-isopropylamino-propan-2-ol
1-{4-[2-(Cyclopropylmethoxy)ethyl]phenoxy}-3-(isopropylamino)propan-2-ol hydrochloride (1:1)
Betoptic
Betaxololum [INN-Latin]
Betazolol
2-propanol, 1-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]-3-[(1-methylethyl)amino]-, hydrochloride
UNII:6X97D2XT0O
Description Betaxolol is a selective beta1 adrenergic receptor blocker used in the treatment of hypertension and glaucoma.Target: Beta1 Adrenergic ReceptorBetaxolol is a cardioselective beta-adrenergic receptor blocking agent. Betaxolol (5 mg/kg via i.p. injection) was administered at 24 and then 44 h following the final chronic cocaine administration. Animals treated with betaxolol during cocaine withdrawal exhibited a significant attenuation of anxiety-like behavior characterized by increased time spent in the open arms and increased entries into the open arms compared to animals treated with only saline during cocaine withdrawal. Betaxolol did not produce anxiolytic-like effects in control animals treated chronically with saline [1]. Betaxolol produces less systemic beta 2- and possibly beta 1-adrenergic receptor blockade than either timolol or levobunolol. Betaxolol may be relatively safer to use in patients with reactive airway disease than either timolol or levobunolol [2].
Related Catalog
References

[1]. Rudoy, C.A. and E.J. Van Bockstaele, Betaxolol, a selective beta(1)-adrenergic receptor antagonist, diminishes anxiety-like behavior during early withdrawal from chronic cocaine administration in rats. Prog Neuropsychopharmacol Biol Psychiatry, 2007. 31(5

[2]. Lesar, T.S., Comparison of ophthalmic beta-blocking agents. Clin Pharm, 1987. 6(6): p. 451-63.

Density 1.067 g/cm3
Boiling Point 448ºC at 760 mmHg
Melting Point 61-63°C
Molecular Formula C18H29NO3
Molecular Weight 307.43
Flash Point 224.7ºC
PSA 50.72000
LogP 2.78430
Storage condition -20°C Freezer

CHEMICAL IDENTIFICATION

RTECS NUMBER :
UA9822500
CHEMICAL NAME :
2-Propanol, 1-(4-(2-(cyclopropylmethoxy)ethyl)phenoxy)-3-((1-meth ylethyl)amino)-
CAS REGISTRY NUMBER :
63659-18-7
LAST UPDATED :
199506
DATA ITEMS CITED :
1
MOLECULAR FORMULA :
C18-H29-N-O3
MOLECULAR WEIGHT :
307.48

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Mammal - dog
DOSE/DURATION :
60 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
YACHDS Yakuri to Chiryo. Pharmacology and Therapeutics. (Raifu Saiensu Shuppan K.K., 2-5-13, Yaesu, Chuo-ku, Tokyo 104, Japan) V.1- 1972- Volume(issue)/page/year: 18(Suppl 7),S1629,1990
Hazard Codes Xi
Risk Phrases R36/37/38:Irritating to eyes, respiratory system and skin .
Safety Phrases S26
WGK Germany 3
RTECS GW2967200

~86%

63659-18-7 structure

63659-18-7

Literature: Joshi, Ramesh Anna; Murugan, Muthukrishnan; Garud, Dinesh Ramesh; Borikar, Sanjay Pandurang; Gurjar, Mukund Keshav Patent: US2006/94903 A1, 2006 ; Location in patent: Page/Page column 5 ;

~92%

63659-18-7 structure

63659-18-7

Literature: Di Bono; Scilimati Synthesis, 1995 , # 6 p. 699 - 702

~%

63659-18-7 structure

63659-18-7

Literature: Journal of Medicinal Chemistry, , vol. 30, # 6 p. 1003 - 1011

~%

63659-18-7 structure

63659-18-7

Literature: Journal of Medicinal Chemistry, , vol. 30, # 6 p. 1003 - 1011

~%

63659-18-7 structure

63659-18-7

Literature: Journal of Medicinal Chemistry, , vol. 30, # 6 p. 1003 - 1011

~%

63659-18-7 structure

63659-18-7

Literature: Journal of Medicinal Chemistry, , vol. 30, # 6 p. 1003 - 1011